Key result
Hyperinsulinemia linked to ~2-fold higher intestinal apoB-48 production rate.
Cross-Sectional (n=14)
Answers are grounded in this paper and cite their sources.
Reveals elevated intestinal apolipoprotein B-48 production in hyperinsulinemic men, indicating that insulin resistance drives gut lipoprotein overproduction.
OBJECTIVE: Whereas postprandial hyperlipidemia is a well-described feature of insulin-resistant states and type 2 diabetes, no previous studies have examined intestinal lipoprotein production rates (PRs) in relation to hyperinsulinemia or insulin resistance in humans. METHODS AND RESULTS: Apolipoprotein B-48 (apoB-48)-containing lipoprotein metabolism was examined in the steady-state fed condition with a 15-hour primed constant infusion of [D3]-l-leucine in 14 nondiabetic men with a broad range of body mass index (BMI) and insulin sensitivity. To examine the relationship between indices of insulin resistance and intestinal lipoprotein PR data were analyzed in 2 ways: by correlation and by comparing apoB-48 PRs in those whose fasting plasma insulin concentrations were above or below the median for the 14 subjects studied (60 pmol/L). ApoB-48 PR was significantly higher in hyperinsulinemic, insulin-resistant subjects (1.73+/-0.39 versus 0.88+/-0.13 mg/kg per day; P<0.05) and correlated with fasting plasma insulin concentrations (r=0.558; P=0.038), despite great heterogeneity in apoB-48 kinetic parameters, particularly among the obese subjects. There was no significant difference in clearance of apoB-48 between the 2 groups, nor was there a significant correlation between apoB-48 fractional clearance rate and fasting insulin or homeostasis model assessment-insulin resistance. CONCLUSIONS: These are the first human data to conclusively demonstrate that intestinal apoB-48-containing triglyceride-rich lipoprotein PR is increased in hyperinsulinemic, insulin-resistant humans. Intestinal lipoprotein particle overproduction is a newly described feature of insulin resistance in humans.
No takes yet. Share an insight, caveat, or question.
Duez et al. (2006) conducted a cross-sectional in Hyperinsulinemia and insulin resistance (n=14). Hyperinsulinemia (fasting plasma insulin above median of 60 pmol/L) vs. Normoinsulinemia (fasting plasma insulin below median of 60 pmol/L) was evaluated on Intestinal apolipoprotein B-48 (apoB-48)-containing lipoprotein production rate (mg/kg per day) (r=0.558, p=<0.05). Hyperinsulinemia was associated with a higher intestinal apoB-48 lipoprotein production rate compared to lower fasting insulin.
Synapse has enriched 10 related papers. Consider them for comparative context: